Popular filter options for Montana Clinical Trials trials
Phase 3 Clinical Trials
View 99 phase 3 medical studies.
Bruton's Tyrosine Kinase (BTK) Inhibitor
Ibrutinib + Stem Cell Transplant for Lymphoma
Recruiting1 awardPhase 3
Billings, Montana
This trial is studying whether adding ibrutinib to chemotherapy before and after stem cell transplant helps the transplant work better in patients with relapsed or refractory diffuse large B-cell lymphoma.
Checkpoint Inhibitor
Nivolumab + Ipilimumab + Sargramostim for Advanced Melanoma
Recruiting1 awardPhase 2 & 3
Greeley, Colorado
This trial is studying nivolumab and ipilimumab to see how well they work with or without sargramostim in treating patients with stage III-IV melanoma that cannot be removed by surgery.
BRAF Inhibitor
Immunotherapy + Targeted Therapy for Melanoma
Recruiting2 awardsPhase 3
Fort Collins, Colorado
This trial is testing two different treatments for melanoma that cannot be removed by surgery. The first treatment is immunotherapy with monoclonal antibodies, followed by targeted therapy with dabrafenib and trametinib. The second treatment is targeted therapy with dabrafenib and trametinib, followed by immunotherapy with monoclonal antibodies. It is not yet known which treatment is more effective.
Tyrosine Kinase Inhibitor
Crizotinib for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Kingman, Arizona
This trial studies crizotinib for patients with stage IB-IIIA NSCLC who have had surgery and have an ALK fusion mutation. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working.
Platinum-based Chemotherapy
Radiation Therapy + Chemotherapy for Cervical Cancer
Recruiting2 awardsPhase 3
Greeley, Colorado
This trial compares radiation therapy with chemotherapy to radiation therapy alone to see which is more effective in treating patients with early cervical cancer who have already undergone surgery.
Clinical Trials With No Placebo
View 99 medical studies that do not have a placebo group.
Checkpoint Inhibitor
Nivolumab + Ipilimumab + Sargramostim for Advanced Melanoma
Recruiting1 awardPhase 2 & 3
Greeley, Colorado
This trial is studying nivolumab and ipilimumab to see how well they work with or without sargramostim in treating patients with stage III-IV melanoma that cannot be removed by surgery.
BRAF Inhibitor
Immunotherapy + Targeted Therapy for Melanoma
Recruiting2 awardsPhase 3
Fort Collins, Colorado
This trial is testing two different treatments for melanoma that cannot be removed by surgery. The first treatment is immunotherapy with monoclonal antibodies, followed by targeted therapy with dabrafenib and trametinib. The second treatment is targeted therapy with dabrafenib and trametinib, followed by immunotherapy with monoclonal antibodies. It is not yet known which treatment is more effective.
Tyrosine Kinase Inhibitor
Crizotinib for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Kingman, Arizona
This trial studies crizotinib for patients with stage IB-IIIA NSCLC who have had surgery and have an ALK fusion mutation. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working.
Platinum-based Chemotherapy
Radiation Therapy + Chemotherapy for Cervical Cancer
Recruiting2 awardsPhase 3
Greeley, Colorado
This trial compares radiation therapy with chemotherapy to radiation therapy alone to see which is more effective in treating patients with early cervical cancer who have already undergone surgery.
View More Montana Clinical Trials Trials
See another 85 medical studies focused on Montana Clinical Trials.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.